Eli Lilly & Co. vs. Spyre Therapeutics, Inc. Common Stock
Eli Lilly & Co. and Spyre Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | SYRE | |
|---|---|---|
| Market Cap | $1.04 trillion | $7.52 billion |
LLY leads on 1 of 1 size & scale factors.
Dividend
| LLY | SYRE | |
|---|---|---|
| Dividend Yield | 0.57% | — |
LLY and SYRE split the dividend factors evenly.
Risk & Sentiment
| LLY | SYRE | |
|---|---|---|
| Short Interest | 1.29% | 0.20% |
SYRE leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, SYRE overview, SYRE financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.